Optologix is Discovery Tools (Healthcare) in United States that focus on light-activatable gene business. Founded in 2015. They cover business area such as developer, light-activatable gene regulatory tool, cancer, light-activatable gene regulatory reagent, medical scientist, cellular malignancy, light ray, toxic chemical test, pharma and biotech organization, efficiency, accuracy, resolution, biological experiment, cell line, animal model.
2015
( 9 years old in 2024 )
Light-activatable Gene
-
615 Canty Street
Dallas, TX 75208
United States
Private
developerlight-activatable gene regulatory toolcancerlight-activatable gene regulatory reagentmedical scientistcellular malignancylight raytoxic chemical testpharma and biotech organizationefficiencyaccuracyresolutionbiological experimentcell lineanimal model
* We use standard office opening hours in near Optologix's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Optologix is Discovery Tools (Healthcare) business from United States that founded in 2015 (9 years old in 2024), Optologix business is focusing on Light-activatable Gene.
Optologix headquarter office and corporate office address is located in 615 Canty Street Dallas, TX 75208 United States.
Optologix was founded in United States.
In 2024, Optologix is currently focus on light-activatable gene sector.
Above is snippet of Google Trends for "light-activatable gene" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Optologix, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
